clinical trial · NCT06847399
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Obesity and OverweightBinge Eating DisorderTirzepatideLisdexamfetamine DimesylateGuided self-help cognitive behavioral therapyPlacebo (oral)Placebo (injection)
brief summary
The purpose of this study is to assess the efficacy and safety of tirzepatide in adults with obesity and binge-eating disorder, comparing tirzepatide against placebo and lisdexamfetamine dimesylate. All participants will receive guided self-help cognitive behavioral therapy.
started
Sep 17, 2025
primary completion
Dec 1, 2027
completion
Dec 1, 2027
last updated
Sep 22, 2025
official title
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder: A Randomized Clinical Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol